Centurion Wealth Management’s Vanguard Dividend Appreciation ETF VIG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.03M Sell
21,240
-226
-1% -$51.9K 1.2% 19
2026
Q1
$4.62M Sell
21,466
-193
-0.9% -$43K 1.04% 22
2025
Q4
$4.76M Sell
21,659
-340
-2% -$74.3K 1.04% 25
2025
Q3
$4.75M Buy
21,999
+5,198
+31% +$1.09M 1.08% 24
2025
Q2
$3.44M Buy
16,801
+560
+3% +$109K 0.99% 26
2025
Q1
$3.18M Hold
16,241
1% 25
2024
Q4
$3.18M Buy
16,241
+121
+0.8% +$24.2K 0.99% 25
2024
Q3
$3.19M Buy
+16,120
New +$3.07M 1.02% 24
2024
Q1
$3.03M Sell
16,597
-603
-4% -$106K 1.19% 19
2023
Q4
$2.93M Buy
17,200
+890
+5% +$143K 1.25% 17
2023
Q3
$2.53M Buy
16,310
+1,339
+9% +$217K 1.24% 20
2023
Q2
$2.43M Buy
14,971
+1,988
+15% +$311K 1.17% 20
2023
Q1
$2M Buy
12,983
+1,988
+18% +$305K 1.01% 24
2022
Q4
$1.67M Buy
+10,995
New +$1.64M 0.94% 22

Other funds holding VIG

Centurion Wealth Management's VIG Position: Q2 2026 in Review

Centurion Wealth Management reduced its Vanguard Dividend Appreciation ETF (VIG) stake by 1.1% in Q2 2026, selling an estimated $51.9K and leaving 21,240 shares worth $5.03M. The position accounts for 1.2% of the portfolio, ranked #19.

Centurion Wealth Management first reported a position in VIG in Q4 2022 and has held it in 14 quarters since. 533 funds tracked by Wall St. Rank hold VIG as of Q2 2026.

  • Centurion Wealth Management held 21,240 shares of Vanguard Dividend Appreciation ETF worth $5.03M as of Q2 2026.
  • Centurion Wealth Management sold 226 Vanguard Dividend Appreciation ETF shares in Q2 2026, an estimated $51.9K.
  • Vanguard Dividend Appreciation ETF made up 1.2% of Centurion Wealth Management's portfolio in Q2 2026, its #19 holding.
  • Centurion Wealth Management first reported a position in Vanguard Dividend Appreciation ETF in Q4 2022 and has held it in 14 quarters since.
  • 533 funds tracked by Wall St. Rank held Vanguard Dividend Appreciation ETF as of Q2 2026.

Based on Centurion Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.